NatureWise Biotech & Medicals Corporation (TPEX:4732)

TPEX:4732 Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,165	1,230	1,343	1,737	2,534	1,207
Market Cap Growth	-8.42%	-8.42%	-22.70%	-31.42%	109.96%	5.06%
Enterprise Value	596	745	830	1,225	2,072	769
Last Close Price	23.60	25.00	23.73	30.17	43.55	20.65
PE Ratio	1299.09	1371.24	132.72	57.87	82.24	18.47
PS Ratio	5.19	5.48	8.39	7.60	10.14	3.93
PB Ratio	1.49	1.57	2.12	2.71	4.06	2.02
P/TBV Ratio	1.64	1.73	2.25	2.90	4.39	2.21
P/FCF Ratio	-	-	21.70	125.42	75.14	22.10
P/OCF Ratio	-	-	21.59	125.42	75.14	21.72
EV/Sales Ratio	2.66	3.32	5.18	5.36	8.29	2.51
EV/EBITDA Ratio	-	-	84.38	32.99	54.51	11.74
EV/EBIT Ratio	-	-	241.67	46.51	76.80	13.28
EV/FCF Ratio	-204.77	-	13.41	88.45	61.45	14.09
Debt / Equity Ratio	0.00	0.00	0.01	0.00	0.01	0.01
Debt / EBITDA Ratio	-	-	0.56	0.07	0.17	0.04
Debt / FCF Ratio	-	-	0.13	0.20	0.20	0.05
Asset Turnover	0.29	0.29	0.23	0.33	0.37	0.49
Inventory Turnover	1.25	1.25	1.02	1.71	2.22	2.93
Quick Ratio	13.35	13.35	9.81	13.03	8.24	10.67
Current Ratio	15.28	15.28	11.55	14.52	9.12	11.54
Return on Equity (ROE)	-0.51%	-0.51%	1.59%	4.74%	5.04%	11.55%
Return on Assets (ROA)	-0.98%	-0.98%	0.31%	2.36%	2.47%	5.72%
Return on Capital (ROIC)	-1.05%	-1.05%	0.33%	2.58%	2.74%	6.35%
Return on Capital Employed (ROCE)	-	-	0.50%	4.10%	4.20%	9.50%
Earnings Yield	0.08%	0.07%	0.75%	1.73%	1.22%	5.41%
FCF Yield	-0.25%	-0.24%	4.61%	0.80%	1.33%	4.52%
Dividend Yield	0.86%	-	0.84%	1.66%	0.69%	0.46%
Payout Ratio	1098.89%	1098.88%	243.53%	49.25%	15.09%	-
Buyback Yield / Dilution	0.15%	0.15%	-0.85%	-0.30%	0.05%	-30.58%
Total Shareholder Return	1.01%	0.15%	-0.01%	1.36%	0.74%	-30.12%

Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.